pivalyloxymethyl butyrate has been researched along with Glioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Entin-Meer, M; Haas-Kogan, DA; Lamborn, KR; Nudelman, A; Rephaeli, A; VandenBerg, SR; Yang, X | 1 |
1 other study(ies) available for pivalyloxymethyl butyrate and Glioma
| Article | Year |
|---|---|
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
Topics: Animals; Butyrates; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Glioma; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Nude; Transplantation, Heterologous | 2007 |